Skip to main content
. 2006 Apr 24;148(4):544–552. doi: 10.1038/sj.bjp.0706738

Figure 4.

Figure 4

(a) NAD(P)H oxidase activity assay in aortas from wt mice. Data are expressed as RLU and presented as mean±s.e.m. NTG treatment for 4 days significantly increased the NAD(P)H oxidase activity, which was abolished by rosuvastatin treatment (rosuvastatin–NTG group). *P<0.05 versus all other groups. (b) NAD(P)H oxidase activity in aortas from eNOS−/− mice. Data are expressed as RLU and presented as mean±s.e.m. NTG treatment for 4 days significantly increased the NAD(P)H oxidase activity, which was abolished by rosuvastatin treatment (rosuvastatin–NTG group). *P<0.05 versus all other groups.